KLF transcription factors in bone diseases.
Haixia WangJuanjuan HanGorbachev DmitriiKe NingXin-An ZhangPublished in: Journal of cellular and molecular medicine (2024)
Krüppel-like factors (KLFs) are crucial in the development of bone disease. They are a family of zinc finger transcription factors that are unusual in containing three highly conserved zinc finger structural domains interacting with DNA. It has been discovered that it engages in various cell functions, including proliferation, apoptosis, autophagy, stemness, invasion and migration, and is crucial for the development of human tissues. In recent years, the role of KLFs in bone physiology and pathology has received adequate attention. In addition to regulating the normal growth and development of the musculoskeletal system, KLFs participate in the pathological process of the bones and joints and are intimately linked to several skeletal illnesses, such as osteoarthritis (OA), rheumatoid arthritis (RA), osteoporosis (OP) and osteosarcoma (OS). Consequently, targeting KLFs has emerged as a promising therapeutic approach for an array of bone disorders. In this review, we summarize the current literature on the importance of KLFs in the emergence and regulation of bone illnesses, with a particular emphasis on the pertinent mechanisms by which KLFs regulate skeletal diseases. We also discuss the need for KLFs-based medication-targeted treatment. These endeavours offer new perspectives on the use of KLFs in bone disorders and provide prognostic biomarkers, therapeutic targets and possible drug candidates for bone diseases.
Keyphrases
- bone mineral density
- rheumatoid arthritis
- transcription factor
- bone loss
- soft tissue
- postmenopausal women
- bone regeneration
- gene expression
- signaling pathway
- stem cells
- oxidative stress
- healthcare
- cell death
- systematic review
- endothelial cells
- body composition
- emergency department
- high resolution
- bone marrow
- single cell
- epithelial mesenchymal transition
- high throughput
- working memory
- mesenchymal stem cells
- dna binding
- drug delivery
- circulating tumor
- disease activity
- pi k akt